In this study, nearly 38% of Saudi women with PCOS reported extremely severe depression and extreme anxiety, with higher rates linked to young age, divorce, lifestyle advice, and higher BMI.
January 2024 in “University of Zagreb University Computing Centre (SRCE)” In this retrospective study, researchers observed that infertile patients with PCOS have significantly different serum levels of certain hormones, specifically higher AMH and LH, and lower E2 and FSH, compared to infertile women without PCOS.
In this study of Andean Ecuadorian women with PCOS, phenotypes A and B were more prevalent and associated with higher risks of insulin resistance, anovulation, and metabolic disorders compared to phenotypes C and D.
December 2023 in “Journal of family medicine and primary care” This study focused on understanding the psychosocial impact of androgenetic alopecia in Saudi Arabia to potentially improve treatment strategies for hair loss by incorporating stress-coping methods and new therapeutic approaches.
November 2023 in “Curēus” This study in Saudi Arabia found that psychological stress was strongly linked to skin symptoms, with conditions like psoriasis, eczema, acne, rash, and baldness showing significant associations, highlighting the importance of considering stress levels when diagnosing skin issues.
November 2023 in “International Journal of Trichology” In this study, researchers observed that trichoscopy could reliably identify features such as anisotrichosis and signs associated with inflammation and fibrosis in female pattern hair loss, which may aid in assessing disease severity and guiding treatment decisions.
October 2023 in “Dermatology practical & conceptual” This study observed that among 120 patients recovering from COVID-19, severe diffuse hair loss typically began less than two months post-infection, with the majority of patients experiencing a severe degree of hair loss and positive hair pull tests, often alongside vitamin D deficiency.
This study found that androgenic alopecia significantly impaired quality of life among men in the Eastern Province of Saudi Arabia, with younger males and those diagnosed by a doctor experiencing greater quality of life issues, particularly in the symptoms domain.
This study found a high prevalence of stress-related hair loss in Al Majma'ah, Saudi Arabia, particularly among females and individuals aged 31-40, with significant associations between hair loss and stress, psychosocial challenges, and sociodemographic factors.
September 2023 in “Irish Journal of Medical Science (1971 -)” In this study, 61.4% of females infected with COVID-19 reported hair problems, such as telogen effluvium and increased gray hair, with most cases starting or worsening post-infection as confirmed by trichoscopy.
September 2023 in “Clinical, Cosmetic and Investigational Dermatology” This study found a significant negative correlation between serum SHBG levels and androgenetic alopecia severity in women, but not in men, while no significant correlation was observed for testosterone, estradiol, dehydroepiandrosterone sulfate, and vitamin D levels with hair loss severity across genders.
August 2023 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Minoxidil users may experience hair discoloration, especially with long-term use and a family history of gray hair.
This study found that hair loss following COVID-19 infection was frequently observed, especially in women, and awareness of post-COVID-19 acute telogen effluvium was generally low.
July 2023 in “Health science reports” In this study, researchers examined the prevalence of comorbid conditions among 402 alopecia areata patients, finding that hypothyroidism was notably more frequent in women, while hyperlipidemia was more common in men, with overall thyroid function testing suggested for these patients.
July 2023 in “Al-Azhar Assiut Medical Journal” In this study, tinea capitis was identified as the most common cause of noncicatricial alopecia in children, followed by alopecia areata and marginal traction alopecia. Diagnosis using trichoscopy enhanced understanding by revealing specific hair and scalp disorder characteristics.
This study found that 23.2% of surveyed dermatologists in Saudi Arabia prescribe Tofacitinib for alopecia areata, with 72.4% reporting its effectiveness, while 47.7% cited unavailability as the main reason for not prescribing.
May 2023 in “Reproductive Biology and Endocrinology” This study analyzed online information about PCOS and found that while the accuracy of the information was generally high, the readability was poor, suggesting a need for more accessible resources for patients.
April 2023 in “International journal of dermatology and venereology” This study observed distinct dermoscopic features in pityriasis versicolor that could aid in its differentiation from similar skin disorders.
March 2023 in “Journal of skin and stem cell” This study concluded that trichoscopy is a reliable, non-invasive, and faster diagnostic method for ambiguous cases of alopecia.
January 2023 in “Research Square (Research Square)” This study found that patients with COVID-19 infection lasting longer than two weeks experienced more severe post-infection hair loss, with women and older individuals particularly affected.
January 2023 in “Austin Journal of Obstetrics and Gynecology” This study found that in a sample of girls and adolescents aged 15–24 years, the prevalence of PCOS was 22.5% according to the Rotterdam criteria.
December 2022 in “Journal of Sulaimani Medical College” This study observed that laparoscopic sleeve gastrectomy significantly reduced BMI and helped improve or eliminate certain obesity-related comorbidities over six months, with a low incidence of postoperative complications.
October 2022 in “JAAD international” This study found that more than 70% of patients with autoimmune blistering diseases experienced alopecia, with about 10% having scarring alopecia, and elevated Dsg1 ratios were linked to hair loss in pemphigus vulgaris.
March 2022 in “Journal of The American Academy of Dermatology” This study characterized the incidence of hair loss patterns among men of different races, highlighting a lack of direct racial comparisons in previous research.
January 2022 in “World journal of pharmaceutical sciences” In this study, irregular menstruation was observed as the most common clinical manifestation of polycystic ovarian disorder in the subjects, followed by dermatologic symptoms like hirsutism and acne.
January 2022 in “Journal of Dermatology and Dermatologic Surgery” This study found that trichoscopy is a valuable tool for diagnosing various hair disorders by identifying specific trichoscopic patterns, such as hair diameter diversity in androgenetic alopecia and exclamatory marks in alopecia areata.
November 2021 in “International Journal of Research in Dermatology” This study found that lower hemoglobin and serum ferritin levels were significantly associated with male pattern hair loss in patients diagnosed with non-cicatricial alopecia.
October 2021 in “International Journal of Research in Dermatology” This study found that individuals with alopecia areata had significantly lower vitamin D levels compared to healthy controls, and lower vitamin D levels were associated with more severe hair loss.
July 2021 in “International journal of innovative research in medical science” This study found that 9.1% of surveyed previously-infected adult residents in Saudi Arabia reported skin symptoms related to COVID-19, with rashes being the most common.
April 2021 in “International Journal of Research in Dermatology” This study found that hormonal abnormalities are not very common in adult females with acne, although some patients showed indicators of hyperandrogenism.